Effective immediately, Genaissance will no longer trade on Nasdaq under the ticker symbol GNSC. Clinical Data's Nasdaq ticker symbol is CLDA.
Clinical Data announced the $56 million all-stock acquisition in June. Genaissance will continue to market its DNA and pharmacogenomics services, the company said.
Clinical Data is still in the process of acquiring biomarker discovery firm Icoria, "which will add additional capabilities in the area of molecular diagnostics," according to a company statement today.